Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $7.3700 (-9.79%) ($7.3700 - $7.3700) on Fri. Apr. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 41.88% (three month average) | RSI | 43 | Latest Price | $7.3700(-9.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -3.4% a day on average for past five trading days. | Weekly Trend | EYES declines -0.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) KWEB(29%) MCHI(58%) XLE(33%) TBT(23%) XOP(22%) | Factors Impacting EYES price | EYES will decline at least -20.94% in a week (0% probabilities). PCY(-61%) TIP(-98%) EWY(-33%) LQD(-32%) XLY(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -20.94% (StdDev 41.88%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-29.13(-495.25%) | Resistance Level | $8.91 | 5 Day Moving Average | $8.14(-9.46%) | 10 Day Moving Average | $8.27(-10.88%) | 20 Day Moving Average | $8.91(-17.28%) | To recent high | -52.4% | To recent low | 27.3% | Market Cap | $2.354b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |